ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,052,924 | +1333.5% | 14,346 | +1004.4% | 2.26% | +1033.2% |
| Q4 2022 | $492,000 | -97.8% | 1,299 | -98.0% | 0.20% | -96.8% |
| Q3 2022 | $22,649,000 | -27.7% | 64,152 | -22.5% | 6.22% | -51.6% |
| Q2 2022 | $31,347,000 | +177.1% | 82,735 | +130.6% | 12.84% | +190.5% |
| Q1 2022 | $11,313,000 | -33.2% | 35,880 | -25.8% | 4.42% | -33.7% |
| Q4 2021 | $16,931,000 | +777.7% | 48,347 | +654.5% | 6.67% | +956.4% |
| Q2 2021 | $1,929,000 | – | 6,408 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |